Latest filing published 12 May 2016 for Tempest Therapeutics, Inc., €20k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -79.5%Entry US$20,387.25 · Close at T+365 US$4,182.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Paul W.D. Chapman: trading record in brief
Paul W.D. Chapman has a single filing on record, published on 12 May 2016: an open-market purchase of €20k in Tempest Therapeutics, Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paul W.D. Chapman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,100 shares@ US$7.37100.0% of flowCommon StockSEC:0001179110-16-024356:0Canonical exit: 8 Aug 2016 (T+90)
1 of 1 declaration
